search
Back to results

The Prevention Program for Alzheimer's Related Delirium (PREPARED) Trial (PREPARED)

Primary Purpose

Delirium, Dementia

Status
Suspended
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
PREPARED Trial Intervention
Sponsored by
McGill University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Delirium focused on measuring delirium, dementia, long-term care, cluster randomized trial, nursing, geriatrics

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • has dementia and/or cognitive impairment (as determined by discussions with the nursing staff and chart abstraction);
  • a minimum length of stay in the LTC institution of at least two weeks prior to the start of the baseline assessments;
  • at high risk of delirium, as indicated by a score of 3 or higher on a validated 5-item delirium risk screening tool;
  • delirium-free at baseline, as assessed by the Confusion Assessment Method (CAM), the Delirium Index (DI) and a brief chart review over a screening period of two consecutive weeks.

Exclusion Criteria:

  • unable to communicate verbally in English or French (as determined by either the nursing staff or two consecutive 0-score administrations of the composite cognitive interview at screening);
  • has a history of specific psychiatric conditions (bipolar disorder, depression with signs of psychosis, and psychotic disorders) or intellectual disability;
  • is receiving comfort/end-of-life care.

Sites / Locations

  • Association des établissements privés conventionnés
  • Integrated University Health and Social Services Centre for East Montreal
  • Integrated University Health and Social Services Centre for North Montreal
  • Integrated University Health and Social Services Centre for South-Central Montreal
  • Integrated University Health and Social Services Centre for West Montreal
  • Integrated University Health and Social Services Centre for West-Central Montreal

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

PREPARED Trial Intervention

Care as Usual

Arm Description

Participating nursing staff will be trained to apply the PREPARED Trial interventions, and will apply this knowledge to modify the therapeutic nursing plans of residents under their care who are enrolled in the study, accordingly.

Participating nursing staff will only be provided with general information about delirium, but will not be trained or instructed to modify the therapeutic nursing plans that are in place for residents enrolled in the study. However, at the end of the follow-up period, nursing staff in the control arm will be provided with the PREPARED Trial intervention training program (including bedside coaching), which they can then use after the study has ended at their facility.

Outcomes

Primary Outcome Measures

Incidence of delirium
Confusion Assessment Method (CAM) scores
Delirium severity
Delirium Index scores (0-21)
Delirium episode duration
the total number of days that a given resident experiences active episode(s) of delirium
Number of delirium episodes
count of delirium episodes

Secondary Outcome Measures

Delirium motoric subtype
Delirium Motor Subtype Scale scores
Number of falls
count of falls and fall-related injuries, as documented in medical charts
Time to first fall
days to first reported fall
Change in functional autonomy
Barthel Index (Shah version) scores
Change in cognitive functioning
Hierarchic Dementia Scale scores
Change in level of social engagement
Revised Index of Social Engagement in Long-Term Care Facilities scores

Full Information

First Posted
August 20, 2018
Last Updated
July 13, 2022
Sponsor
McGill University
search

1. Study Identification

Unique Protocol Identification Number
NCT03718156
Brief Title
The Prevention Program for Alzheimer's Related Delirium (PREPARED) Trial
Acronym
PREPARED
Official Title
The Prevention Program for Alzheimer's Related Delirium (PREPARED) Cluster Randomized Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Suspended
Why Stopped
COVID-19 prevented us from continuing this study which involves active participation from long-term care front-line staff. More funding is being sought to continue our trial
Study Start Date
June 23, 2018 (Actual)
Primary Completion Date
June 2025 (Anticipated)
Study Completion Date
June 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
McGill University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
By the year 2038, over a million Canadians are expected to have Alzheimer's disease, a type of dementia. Dementia increases the risk of nursing home placement among the elderly more than fivefold. Given the exceptionally vulnerable nature of this patient population, there is a pressing need to ensure that the clinical care they receive is evidence-based, tailored specifically for them, and meeting the high standards of quality that would be expected in any other health-care setting. Delirium is a sudden and severe change in brain function that can cause a person to appear confused or disoriented, have memory loss, and have difficulties maintaining focus. It is an urgent care issue facing elderly patients residing in nursing homes, or long-term care (LTC) facilities. Delirium is a significant cause of illness and mortality, affecting between 10%-89% of LTC patients, but little research has focused on delirium prevention in the LTC setting. This study will assess the effectiveness of a LTC multicomponent delirium prevention program (PREPARED Trial intervention). The PREPARED Trial intervention is an intervention provided to nursing staff working in LTC facilities that consists of four components: a decision tree, an instruction manual, a training package, and a toolkit. The feasibility and acceptability of the PREPARED Trial intervention has already been successfully demonstrated; however, a thorough and well-designed large scale study is needed in order to confirm its ability to reduce delirium among LTC residents. In this study, approximately 40-50 LTC facilities will be randomized to either receive the PREPARED Trial intervention or to receive usual care. At the end of the 4-year study period, the investigators will be able to demonstrate the degree to which the PREPARED Trial intervention reduces: 1) the number of new cases of delirium; 2) delirium severity; and 3) the duration of delirium episodes. This study will provide the blueprint of a program that can be transferable to LTC facilities across Canada.
Detailed Description
Overall Goal: To reduce the incidence, severity, duration, and frequency of delirium episodes in cognitively impaired long-term care (LTC) residents at high risk for delirium. Background: Delirium is a significant cause of morbidity and mortality among older people admitted to both acute and LTC settings. Prevention, founded on a thorough understanding of associated risk factors, is the best approach for dealing with delirium. Several successful multicomponent interventions have been developed to reduce delirium incidence in the acute care setting (30%-73% reduction) by intervening on identified modifiable risk factors. Little work, however, has focused on using this approach to reduce delirium incidence in LTC. As such, co-investigators within the study team employed an integrated knowledge translation strategy to develop a LTC multicomponent delirium prevention program (PREPARED Trial intervention). The feasibility and acceptability of this program has been demonstrated using a participatory approach in two Quebec LTC facilities (LTCFs), and the program has received recognition by the scientific community. Given its large expected impact and high knowledge translation potential, a thorough and well-designed large-scale evaluation is urgently needed in order to demonstrate the effectiveness of the multicomponent delirium prevention program in preventing delirium among high-risk LTC residents. Primary Objective: To assess efficacy of the PREPARED Trial intervention in reducing delirium incidence, and delirium episode severity, duration, and frequency among cognitively impaired, high-risk LTC residents. Secondary Objectives: To compare the effect of the PREPARED Trial intervention to that of usual care on the incidence of falls among cognitively impaired LTC residents, to estimate the association between medication use and delirium incidence in LTCFs, to estimate if there is an effect modification by motor subtype of delirium or by dementia subtype, and to measure the prevalence of delirium in participating institutions. Tertiary Objectives: To compare the effect of the PREPARED Trial intervention on other health outcomes, including: changes in functional autonomy or social engagement, the number of transfers to acute care, consultations with healthcare providers, and mortality rates. Methods: This 4-year cluster randomized study will involve nursing staff and residents in 40-50 public and semi-private LTC facilities in Quebec, Canada. Institutions within all 5 of the Montreal island Integrated University Health and Social Services networks (CIUSSS) and one private provincial network are currently participating. Approximately 900 LTC residents will be enrolled in the study and followed for 18 weeks only if they are at high risk of delirium and are delirium-free at baseline. The PREPARED Trial intervention is a program consisting of four components: a decision tree, an instruction manual, a training package and a toolkit. Primary study outcomes such as delirium incidence (measured by the Confusion Assessment Method), delirium severity (measured by the Delirium Index), and level of adherence to the PREPARED Trial protocol will be assessed weekly. Functional autonomy levels will be assessed at the beginning and end of follow-up, while information pertaining to modifiable delirium risk factors, medical consultations, and institutional transfers will be collected for the duration of the follow-up period. For primary analysis, hazard ratios will be modeled using Cox regression to compare the effect of the PREPARED Trial intervention to that of usual care on the time to first delirium episode. Clustering effects will be taken into account using frailty models, an extension of Cox regression for the addition of random effects. Expected Outcomes and Significance: This large-scale intervention study will contribute significantly to the development of evidence-based clinical guidelines for delirium prevention in this frail elderly population, as it will be the first to evaluate the efficacy of a multicomponent delirium prevention program translated into LTC clinical practice on a large scale. In addition to reducing delirium in this frail population, deliverables include validation of this prevention program, as well as the transferring of its components (including bilingual video training modules for LTC staff) to relevant knowledge users across Canada.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Delirium, Dementia
Keywords
delirium, dementia, long-term care, cluster randomized trial, nursing, geriatrics

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The PREPARED Trial is a 4-year cluster randomized intervention study. A cluster design was adopted in order to prevent contamination across the intervention and control arms by nursing staff who may provide replacement hours of employment at different units/floors within their long-term care facilities (LTCFs). Participating LTCFs (clusters) will be assigned to either the PREPARED Trial intervention or the control (usual care) arm of the study using a covariate constrained randomization procedure. In addition, given the need to assess each resident weekly for a follow-up period of 18 weeks and logistical limitations (large geographical coverage, 40-50 LTCFs included, and limited work force), the investigators will employ a sequential approach whereby sets of clusters (LTCFs) will be randomized into the two study arms in consecutive 'waves' of follow-up lasting 18 weeks each. It is estimated that 4 waves of trial follow-up, comprised of 10-12 clusters each, will be completed.
Masking
None (Open Label)
Masking Description
Long-term care facilities (LTCFs) cannot be blinded, as trial arm allocation will be obvious (those in the intervention group will undergo delirium prevention protocol training before their respective follow-up periods, and those in the control group will not). Similarly, research assistants (RAs) tasked with conducting resident assessments cannot be blinded to group allocation, as they will be constantly exposed to the everyday workings of participating LTCFs. However, RAs will be blinded to resident cognitive scores. All researchers analyzing the data will be blinded to group allocation, as LTCF names will be anonymized and randomization statuses will be concealed prior to data analysis.
Allocation
Randomized
Enrollment
800 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
PREPARED Trial Intervention
Arm Type
Experimental
Arm Description
Participating nursing staff will be trained to apply the PREPARED Trial interventions, and will apply this knowledge to modify the therapeutic nursing plans of residents under their care who are enrolled in the study, accordingly.
Arm Title
Care as Usual
Arm Type
No Intervention
Arm Description
Participating nursing staff will only be provided with general information about delirium, but will not be trained or instructed to modify the therapeutic nursing plans that are in place for residents enrolled in the study. However, at the end of the follow-up period, nursing staff in the control arm will be provided with the PREPARED Trial intervention training program (including bedside coaching), which they can then use after the study has ended at their facility.
Intervention Type
Other
Intervention Name(s)
PREPARED Trial Intervention
Intervention Description
Nursing staff members will be trained to adjust the therapeutic nursing plans (TNP) for residents enrolled in the study, as follows: 1) by providing optimal stimulation (surveying the use of eyeglasses and hearing aids, the room lighting and space organization; orienting the resident to time and space; and stimulating the resident using familiar objects, photos, and life histories); and 2) by assessing the presence of 4 modifiable delirium risk factors (antipsychotic use, sensory impairment, restraint use, and dehydration) and taking specific actions once a given risk factor is identified. For instance, if physical restraints are used, the TNP will require that they are to be removed during care when a caregiver is present (nail care, feeding, and wound care).
Primary Outcome Measure Information:
Title
Incidence of delirium
Description
Confusion Assessment Method (CAM) scores
Time Frame
over the 18 week follow-up period
Title
Delirium severity
Description
Delirium Index scores (0-21)
Time Frame
over the 18 week follow-up period
Title
Delirium episode duration
Description
the total number of days that a given resident experiences active episode(s) of delirium
Time Frame
over the 18 week follow-up period
Title
Number of delirium episodes
Description
count of delirium episodes
Time Frame
over the 18 week follow-up period
Secondary Outcome Measure Information:
Title
Delirium motoric subtype
Description
Delirium Motor Subtype Scale scores
Time Frame
over the 18 week follow-up period
Title
Number of falls
Description
count of falls and fall-related injuries, as documented in medical charts
Time Frame
over the 18 week follow-up period
Title
Time to first fall
Description
days to first reported fall
Time Frame
over the 18 week follow-up period
Title
Change in functional autonomy
Description
Barthel Index (Shah version) scores
Time Frame
over the study period (18 weeks)
Title
Change in cognitive functioning
Description
Hierarchic Dementia Scale scores
Time Frame
over the study period (18 weeks)
Title
Change in level of social engagement
Description
Revised Index of Social Engagement in Long-Term Care Facilities scores
Time Frame
over the study period (18 weeks)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: has dementia and/or cognitive impairment (as determined by discussions with the nursing staff and chart abstraction); a minimum length of stay in the LTC institution of at least two weeks prior to the start of the baseline assessments; at high risk of delirium, as indicated by a score of 3 or higher on a validated 5-item delirium risk screening tool; delirium-free at baseline, as assessed by the Confusion Assessment Method (CAM), the Delirium Index (DI) and a brief chart review over a screening period of two consecutive weeks. Exclusion Criteria: unable to communicate verbally in English or French (as determined by either the nursing staff or two consecutive 0-score administrations of the composite cognitive interview at screening); has a history of specific psychiatric conditions (bipolar disorder, depression with signs of psychosis, and psychotic disorders) or intellectual disability; is receiving comfort/end-of-life care.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Machelle Wilchesky, PhD
Organizational Affiliation
McGill University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Philippe Voyer, Inf. PhD
Organizational Affiliation
Laval University
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Nathalie Champoux, MD, MSc
Organizational Affiliation
Université de Montréal
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Antonio Ciampi, PhD
Organizational Affiliation
McGill University
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Ovidiu Lungu, PhD
Organizational Affiliation
Université de Montréal
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Jane McCusker, MD, PhD
Organizational Affiliation
McGill University
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Johanne Monette, MD, MSc
Organizational Affiliation
Lady Davis Institute for Medical Research
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
T.T. Minh Vu, MD, FRCPC
Organizational Affiliation
Centre hospitalier de l'Université de Montréal (CHUM)
Official's Role
Study Chair
Facility Information:
Facility Name
Association des établissements privés conventionnés
City
Montréal
Country
Canada
Facility Name
Integrated University Health and Social Services Centre for East Montreal
City
Montréal
Country
Canada
Facility Name
Integrated University Health and Social Services Centre for North Montreal
City
Montréal
Country
Canada
Facility Name
Integrated University Health and Social Services Centre for South-Central Montreal
City
Montréal
Country
Canada
Facility Name
Integrated University Health and Social Services Centre for West Montreal
City
Montréal
Country
Canada
Facility Name
Integrated University Health and Social Services Centre for West-Central Montreal
City
Montréal
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
11068569
Citation
Elie M, Rousseau F, Cole M, Primeau F, McCusker J, Bellavance F. Prevalence and detection of delirium in elderly emergency department patients. CMAJ. 2000 Oct 17;163(8):977-81.
Results Reference
background
PubMed Identifier
12366629
Citation
Fick DM, Agostini JV, Inouye SK. Delirium superimposed on dementia: a systematic review. J Am Geriatr Soc. 2002 Oct;50(10):1723-32. doi: 10.1046/j.1532-5415.2002.50468.x.
Results Reference
background
PubMed Identifier
16686883
Citation
Lemiengre J, Nelis T, Joosten E, Braes T, Foreman M, Gastmans C, Milisen K. Detection of delirium by bedside nurses using the confusion assessment method. J Am Geriatr Soc. 2006 Apr;54(4):685-9. doi: 10.1111/j.1532-5415.2006.00667.x.
Results Reference
background
PubMed Identifier
19233058
Citation
Voyer P, Richard S, Doucet L, Carmichael PH. Detecting delirium and subsyndromal delirium using different diagnostic criteria among demented long-term care residents. J Am Med Dir Assoc. 2009 Mar;10(3):181-8. doi: 10.1016/j.jamda.2008.09.006. Epub 2009 Jan 8.
Results Reference
background
PubMed Identifier
21274904
Citation
McCusker J, Cole MG, Voyer P, Monette J, Champoux N, Ciampi A, Vu M, Belzile E. Prevalence and incidence of delirium in long-term care. Int J Geriatr Psychiatry. 2011 Nov;26(11):1152-61. doi: 10.1002/gps.2654. Epub 2011 Jan 27.
Results Reference
background
PubMed Identifier
20224406
Citation
Cole MG. Persistent delirium in older hospital patients. Curr Opin Psychiatry. 2010 May;23(3):250-4. doi: 10.1097/YCO.0b013e32833861f6.
Results Reference
background
PubMed Identifier
12473034
Citation
Cole MG, McCusker J. Treatment of delirium in older medical inpatients: a challenge for geriatric specialists. J Am Geriatr Soc. 2002 Dec;50(12):2101-3. doi: 10.1046/j.1532-5415.2002.50634.x. No abstract available.
Results Reference
background
PubMed Identifier
10053175
Citation
Inouye SK, Bogardus ST Jr, Charpentier PA, Leo-Summers L, Acampora D, Holford TR, Cooney LM Jr. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999 Mar 4;340(9):669-76. doi: 10.1056/NEJM199903043400901.
Results Reference
background
PubMed Identifier
23460093
Citation
Reston JT, Schoelles KM. In-facility delirium prevention programs as a patient safety strategy: a systematic review. Ann Intern Med. 2013 Mar 5;158(5 Pt 2):375-80. doi: 10.7326/0003-4819-158-5-201303051-00003.
Results Reference
background
PubMed Identifier
19754498
Citation
Vidan MT, Sanchez E, Alonso M, Montero B, Ortiz J, Serra JA. An intervention integrated into daily clinical practice reduces the incidence of delirium during hospitalization in elderly patients. J Am Geriatr Soc. 2009 Nov;57(11):2029-36. doi: 10.1111/j.1532-5415.2009.02485.x. Epub 2009 Sep 15.
Results Reference
background
PubMed Identifier
25643002
Citation
Hshieh TT, Yue J, Oh E, Puelle M, Dowal S, Travison T, Inouye SK. Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis. JAMA Intern Med. 2015 Apr;175(4):512-20. doi: 10.1001/jamainternmed.2014.7779. Erratum In: JAMA Intern Med. 2015 Apr;175(4):659.
Results Reference
background
PubMed Identifier
25424450
Citation
Martinez F, Tobar C, Hill N. Preventing delirium: should non-pharmacological, multicomponent interventions be used? A systematic review and meta-analysis of the literature. Age Ageing. 2015 Mar;44(2):196-204. doi: 10.1093/ageing/afu173. Epub 2014 Nov 25.
Results Reference
background
PubMed Identifier
17512095
Citation
Gentric A, Le Deun P, Estivin S. [Prevention of delirium in an acute geriatric care unit]. Rev Med Interne. 2007 Sep;28(9):589-93. doi: 10.1016/j.revmed.2007.04.004. Epub 2007 May 15. French.
Results Reference
background
PubMed Identifier
17698685
Citation
Pisani MA, Murphy TE, Van Ness PH, Araujo KL, Inouye SK. Characteristics associated with delirium in older patients in a medical intensive care unit. Arch Intern Med. 2007 Aug 13-27;167(15):1629-34. doi: 10.1001/archinte.167.15.1629.
Results Reference
background
PubMed Identifier
24094898
Citation
Voyer P, McCusker J, Cole MG, Monette J, Champoux N, Vu M, Ciampi A, Sanche S, Richard S, de Raad M. Feasibility and acceptability of a delirium prevention program for cognitively impaired long term care residents: a participatory approach. J Am Med Dir Assoc. 2014 Jan;15(1):77.e1-9. doi: 10.1016/j.jamda.2013.08.013. Epub 2013 Oct 2.
Results Reference
background
PubMed Identifier
24113630
Citation
Rockwood K. Making delirium prevention acceptable in nursing homes. J Am Med Dir Assoc. 2014 Jan;15(1):6-7. doi: 10.1016/j.jamda.2013.09.002. Epub 2013 Oct 8. No abstract available.
Results Reference
background
PubMed Identifier
2240918
Citation
Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990 Dec 15;113(12):941-8. doi: 10.7326/0003-4819-113-12-941.
Results Reference
background
PubMed Identifier
18384586
Citation
Wei LA, Fearing MA, Sternberg EJ, Inouye SK. The Confusion Assessment Method: a systematic review of current usage. J Am Geriatr Soc. 2008 May;56(5):823-30. doi: 10.1111/j.1532-5415.2008.01674.x. Epub 2008 Apr 1.
Results Reference
background
PubMed Identifier
15450055
Citation
McCusker J, Cole MG, Dendukuri N, Belzile E. The delirium index, a measure of the severity of delirium: new findings on reliability, validity, and responsiveness. J Am Geriatr Soc. 2004 Oct;52(10):1744-9. doi: 10.1111/j.1532-5415.2004.52471.x.
Results Reference
background
Citation
Allison PD (1995) Survival analysis using SAS: A practical guide. Cary, NC: SAS Institute. Inc.
Results Reference
background
Citation
Klein J. ea (2003) Survival Analysis (2nd ed.). New York: Springer.
Results Reference
background
Citation
Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model: Springer Science & Business Media.
Results Reference
background
PubMed Identifier
34784897
Citation
Wilchesky M, Ballard SA, Voyer P, McCusker J, Lungu O, Champoux N, Vu TTM, Cole MG, Monette J, Ciampi A, Belzile E, Carmichael PH, McConnell T. The PREvention Program for Alzheimer's RElated Delirium (PREPARED) cluster randomized trial: a study protocol. BMC Geriatr. 2021 Nov 16;21(1):645. doi: 10.1186/s12877-021-02558-3.
Results Reference
derived

Learn more about this trial

The Prevention Program for Alzheimer's Related Delirium (PREPARED) Trial

We'll reach out to this number within 24 hrs